Following the success of the 2024 workshop in Korea, the PDA CDMO Partnership Workshop returns—this time in Singapore on 5 May 2025! With the Asia-Pacific CDMO market poised for exponential growth, this workshop is tailored to help you capitalize on emerging opportunities, overcome partnership challenges, and stay competitive in the global biopharmaceutical ecosystem.
From crafting winning RFPs to navigating regulatory complexities, attendees will gain actionable insights that address the ever-evolving demands of the pharmaceutical and biopharma industries.
Key Highlights
- Building Winning Partnerships: Learn how to craft standout RFPs, establish robust quality agreements, and effectively manage tech transfers.
- Big Pharma Perspectives: Gain insights into the evaluation process and selection criteria for CDMOs by leading pharmaceutical companies.
- Navigating New Modalities: Understand the technical and strategic considerations for emerging therapies like cell & gene treatments.
- Inspection Readiness: Prepare for regulatory inspections with a focus on quality management systems.
- Comprehensive Tools: Take home a ready-to-use Master Transfer Plan, complete with RACI, timelines, and defined responsibilities.
Why Attend?
As the biopharmaceutical industry embraces innovation and new modalities, the need for strategic and seamless partnerships with CDMOs has never been greater. This workshop will equip you with actionable strategies and best practices to navigate these changes and position your organization for long-term success.
